−26.17 MUSD
55.22 M
About BiomX Inc.
Sector
Industry
CEO
Jonathan Eithan Solomon
Website
Headquarters
Ness Ziona
Employees (FY)
71
Founded
2015
ISIN
US09090D2027
FIGI
BBG00MNV4MH6
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.